I think that is spot on, the recommended rating is basically from PAA's own marketers so I would not expect based on that the SP is headed over 30c. But at a minimum there is some interest here and it will be interesting to see what happens in a few week when they start rolling out some news on starting phase II.
Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharm, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 18.5¢ | $106.2K | 550.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 714303 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 26750 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |